Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
---|---|---|---|---|---|---|
MTCR | Metacrine, Inc. | Chief Business Officer | $48.6K | Jan 26, 2023 | ||
PHASQ | PhaseBio Pharmaceuticals Inc | VP, Corporate Development | May 20, 2021 |
Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
---|